Related references
Note: Only part of the references are listed.Cost-utility of use of sputum eosinophil counts to guide management in children with asthma
Jefferson Antonio Buendia et al.
JOURNAL OF ASTHMA (2022)
SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis
Jefferson Antonio Buendia et al.
JOURNAL OF ASTHMA (2022)
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia
Jefferson Antonio Buendia et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)
Cost-utility of azithromycin in patients with severe asthma
Jefferson Antonio Buendia et al.
JOURNAL OF ASTHMA (2022)
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma
Jefferson Antonio Buendia et al.
JOURNAL OF ASTHMA (2022)
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia
Buendia Jefferson Antonio et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2022)
Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia
Oscar Espinosa et al.
HEALTH POLICY AND PLANNING (2022)
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
Jefferson Antonio Buendia et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2021)
Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
Jefferson Antonio Buendia et al.
BMC PULMONARY MEDICINE (2021)
Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective
Jefferson Antonio Buendia et al.
BMC HEALTH SERVICES RESEARCH (2021)
The cost-utility of early use of high-flow nasal cannula in bronchiolitis
Jefferson Antonio Buendia et al.
HEALTH ECONOMICS REVIEW (2021)
Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective
Jefferson Antonio Buendia et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years
Jefferson Antonio Buendia et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)
Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma
Jefferson Antonio Buendia et al.
PEDIATRIC PULMONOLOGY (2021)
Cost of illness of RSV infection in a middle-income tropical country
Jefferson Antonio Buendia et al.
TURKISH JOURNAL OF PEDIATRICS (2021)
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
Jefferson Antonio Buendia et al.
PHARMACOECONOMICS-OPEN (2021)
The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children
Jefferson A. Buendia et al.
PEDIATRIC PULMONOLOGY (2020)
Treatment outcomes of Pumani bubble-CPAP versus oxygen therapy among preterm babies presenting with respiratory distress at a tertiary hospital in Tanzania-Randomised trial
Annette Baine Mwatha et al.
PLOS ONE (2020)
The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis
Jefferson Antonio Buendia et al.
BMC HEALTH SERVICES RESEARCH (2020)
The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment
Sabine Elisabeth Grimm et al.
PHARMACOECONOMICS (2017)
Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology
Renjithkumar Kalikkot Thekkeveedu et al.
RESPIRATORY MEDICINE (2017)
Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort
Tracy A. Manuck et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample: A Nonparametric Regression Approach
Mark Strong et al.
MEDICAL DECISION MAKING (2014)
Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes
Aaron E. Carroll et al.
JOURNAL OF PEDIATRICS (2009)